RhumbLine Advisers’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.7M Buy
368,706
+28,987
+9% +$1.61M 0.02% 640
2026
Q1
$14.5M Buy
339,719
+56,291
+20% +$2.27M 0.01% 886
2025
Q4
$10.6M Buy
283,428
+150,889
+114% +$5.06M 0.01% 1034
2025
Q3
$3.92M Buy
132,539
+7,881
+6% +$183K ﹤0.01% 1557
2025
Q2
$2.94M Buy
124,658
+47,558
+62% +$992K ﹤0.01% 1673
2025
Q1
$1.39M Buy
77,100
+3,517
+5% +$69.1K ﹤0.01% 2009
2024
Q4
$1.25M Buy
73,583
+1,118
+2% +$19.3K ﹤0.01% 2122
2024
Q3
$1.06M Sell
72,465
-1,178
-2% -$14.8K ﹤0.01% 2236
2024
Q2
$837K Buy
73,643
+12,479
+20% +$136K ﹤0.01% 2337
2024
Q1
$665K Buy
+61,164
New +$612K ﹤0.01% 2487

Other funds holding BTSG

RhumbLine Advisers's BTSG Position: Q2 2026 in Review

RhumbLine Advisers increased its BrightSpring Health Services (BTSG) stake by 8.5% in Q2 2026, buying an estimated $1.61M and bringing the position to 368,706 shares worth $25.7M. The position accounts for 0.02% of the portfolio, ranked #640.

RhumbLine Advisers first reported a position in BTSG in Q1 2024 and has held it in 10 quarters since. 423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

  • RhumbLine Advisers held 368,706 shares of BrightSpring Health Services worth $25.7M as of Q2 2026.
  • RhumbLine Advisers bought 28,987 BrightSpring Health Services shares in Q2 2026, an estimated $1.61M.
  • BrightSpring Health Services made up 0.02% of RhumbLine Advisers's portfolio in Q2 2026, its #640 holding.
  • RhumbLine Advisers first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 10 quarters since.
  • 423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.